Abstract
Tyrosine kinase inhibitors (TKIs) have dramatically changed the way chronic myeloid leukemia (CML) is treated. Although TKI therapy improves the overa......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
